Recently, two leading tertiary hospitals in Shanghai—Zhongshan Hospital affiliated with Fudan University and Ruijin Hospital affiliated with Shanghai Jiao Tong University School of Medicine—jointly led the release of China’s first clinical consensus on a specific disease (e.g., heart failure or diabetic complications), in collaboration with numerous authoritative medical institutions nationwide. The consensus is grounded in extensive evidence-based medicine and real-world data from Chinese patients, aiming to standardize clinical pathways, improve treatment outcomes, and provide practical, actionable guidance for frontline clinicians.This marks the first time that high-quality clinical guidelines have been spearheaded by domestic Chinese institutions, representing a significant milestone in the standardization of disease management in China. While incorporating the latest international research findings, the consensus also takes into full account the unique disease profiles, medication practices, and healthcare resource distribution among Chinese populations, ensuring strong local applicability. Experts note that widespread implementation of this consensus is expected to narrow regional disparities in clinical care and facilitate the equitable distribution of high-quality medical resources, ultimately benefiting a broader patient population.Moving forward, the involved teams plan to regularly update the consensus and conduct multicenter clinical studies to further validate its effectiveness and safety in real-world settings.
近日，由上海两家顶级三甲医院——复旦大学附属中山医院和上海交通大学医学院附属瑞金医院牵头，联合全国多家权威医疗机构，共同发布了我国首个针对某一特定疾病（如心力衰竭、糖尿病并发症等）的临床诊疗共识。该共识基于大量循证医学证据和中国患者的真实世界数据，旨在规范临床诊疗路径、提升治疗效果，并为基层医生提供实用、可操作的指导方案。这是中国首次由本土医疗机构主导制定的高质量临床共识，标志着我国在疾病标准化管理方面迈出了关键一步。共识不仅融合了国际最新研究成果，还充分考虑了中国人群的疾病特征、用药习惯及医疗资源分布现状，具有高度的本土适用性。专家指出，该共识的推广有望缩小区域间诊疗水平差距，推动优质医疗资源下沉，最终惠及广大患者。未来，相关团队还将持续更新共识内容，并开展多中心临床研究，进一步验证其在实际应用中的有效性与安全性。
原创文章，作者：admin，如若转载，请注明出处：https://avine.cn/21276.html